Immuneering's total assets for Q2 2025 were $40.06M, a decrease of -20.96% from the previous quarter. IMRX total liabilities were $11.12M for the fiscal quarter, a 25.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.